Phase 1 Mesothelin-Expressing Tumors Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer

Breast NeoplasmsEsophageal AdenocarcinomaMesothelin Positive+5 more

Memorial Sloan Kettering Cancer Center18 enrolled7 locationsNCT06623396

Recruiting

Phase 1

CT-95 in Advanced Cancers Associated With Mesothelin Expression

Mesothelin-Expressing TumorsEpithelial Ovarian CancerLung Adenocarcinoma Metastatic+7 more

Context Therapeutics Inc.70 enrolled8 locationsNCT06756035